Liposphere’s patented knee joint
articulation injectable under development
CCoat coats the knee joints’ cartilage surface, providing a longlasting mechanical “cushion” to enable ease of movement.
We achieve this cushioning function by utilising robust, yet elastic lipidbased spheres. These spheres hold surrounding water in a unique way, which in combination with their structural 3D morphology, offers highly lubrication during joint articulation.
Disclaimer: Liposphere’s CCoat has not been reviewed or evaluated by the U.S. Food and Drug Administration. CCoat is not designed to diagnose, treat, cure, or prevent any disease and should not be used as a substitute for advice from a healthcare or medical professional.
Clinical
First-In-Human trials
showed that CCoat is safe, reduces wear-associated pain for up to 6 months and leads to improved functionality and sports recovery.
MARKET RELEVANCE
The market standard non-surgical treatments are only partially meeting the needs of knee OA sufferers.
…which means that CCoat as an effective, structural boundary lubricant has the potential to capture significant share in the multi-billion dollar markets of human orthopaedics, sports injuries and pets.
Scaling up and growth
Clear path to growth and
significant valuation upside
Liposphere is currently raising Series B capital to accelerate
CCoat’s development to access the European market.
Only EU
Only Human Knee OA
And Elite Sports
Contact us
Would you like to contact us? Call us or send us a message
using the contact form – looking forward to hearing from you.
Liposphere Ltd.
Aarava 1
6th Floor
Givat-Shmuel 5400804
Israel
Office: +972 (0) 732113227
E-Mail: contact@lipo-sphere.com